Literature DB >> 17931958

Cell-based high-content screening of small-molecule libraries.

Kerstin Korn1, Eberhard Krausz.   

Abstract

Advanced microscopy and the corresponding image analysis have been developed in recent years into a powerful tool for studying molecular and morphological events in cells and tissues. Cell-based high-content screening (HCS) is an upcoming methodology for the investigation of cellular processes and their alteration by multiple chemical or genetic perturbations. Multiparametric characterization of responses to such changes can be analyzed using intact live cells as reporter. These disturbances are screened for effects on a variety of molecular and cellular targets, including subcellular localization and redistribution of proteins. In contrast to biochemical screening, they detect the responses within the context of the intercellular structural and functional networks of normal and diseased cells, respectively. As cell-based HCS of small-molecule libraries is applied to identify and characterize new therapeutic lead compounds, large pharmaceutical companies are major drivers of the technology and have already shown image-based screens using more than 100,000 compounds.

Mesh:

Substances:

Year:  2007        PMID: 17931958     DOI: 10.1016/j.cbpa.2007.08.030

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  35 in total

1.  Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.

Authors:  Heike Glauner; Ivo R Ruttekolk; Kerrin Hansen; Ben Steemers; Yi-Da Chung; Frank Becker; Stefan Hannus; Roland Brock
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Validation of a high-content screening assay using whole-well imaging of transformed phenotypes.

Authors:  Christina N Ramirez; Tatsuya Ozawa; Toshimitsu Takagi; Christophe Antczak; David Shum; Robert Graves; Eric C Holland; Hakim Djaballah
Journal:  Assay Drug Dev Technol       Date:  2010-12-23       Impact factor: 1.738

3.  A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction.

Authors:  Linlin Zhong; Tuan Tran; Tyler D Baguley; Sang Jun Lee; Adam Henke; Andrew To; Sijia Li; Shan Yu; Fabio A Grieco; Jason Roland; Peter G Schultz; Decio L Eizirik; Nikki Rogers; Arnab K Chartterjee; Matthew S Tremblay; Weijun Shen
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

Review 4.  Cell-Based Assay Design for High-Content Screening of Drug Candidates.

Authors:  Gregory Nierode; Paul S Kwon; Jonathan S Dordick; Seok-Joon Kwon
Journal:  J Microbiol Biotechnol       Date:  2016-02       Impact factor: 2.351

Review 5.  High-content screening in microfluidic devices.

Authors:  Raymond Cheong; Saurabh Paliwal; Andre Levchenko
Journal:  Expert Opin Drug Discov       Date:  2010-08       Impact factor: 6.098

6.  Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening.

Authors:  Sarah Straschewski; Martin Warmer; Giada Frascaroli; Heinrich Hohenberg; Thomas Mertens; Michael Winkler
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

7.  High-content, image-based screening for drug targets in yeast.

Authors:  Shinsuke Ohnuki; Satomi Oka; Satoru Nogami; Yoshikazu Ohya
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  Chemical stimulation of adherent cells by localized application of acetylcholine from a microfluidic system.

Authors:  Susanne Zibek; Britta Hagmeyer; Alfred Stett; Martin Stelzle
Journal:  Front Neuroeng       Date:  2010-11-26

Review 9.  Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).

Authors:  Terry W Moore; Christopher G Mayne; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-20

Review 10.  HTS and hit finding in academia--from chemical genomics to drug discovery.

Authors:  Julie A Frearson; Iain T Collie
Journal:  Drug Discov Today       Date:  2009-09-28       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.